These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3863620)

  • 1. Mitoxantrone and bisantrene inhibition of platelet aggregation and prostaglandin E2 production in vitro.
    Frank P; Novak RF
    Biochem Pharmacol; 1985 Oct; 34(19):3609-14. PubMed ID: 3863620
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of mitoxantrone and bisantrene on platelet aggregation and prostaglandin/thromboxane biosynthesis in vitro.
    Frank P; Novak RF
    Anticancer Res; 1986; 6(5):941-7. PubMed ID: 3467648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol-inhibited platelet prostaglandin synthesis in vitro.
    Stuart MJ
    J Stud Alcohol; 1979; 40(1):1-6. PubMed ID: 449324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus.
    Halushka PV; Lurie D; Colwell JA
    N Engl J Med; 1977 Dec; 297(24):1306-10. PubMed ID: 917087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP in human blood platelets: relation to platelet prostaglandin synthesis induced by centrifugation or surface contact.
    Salzman EW; Lindon JN; Rodvien R
    J Cyclic Nucleotide Res; 1976; 2(1):25-37. PubMed ID: 178701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of cyclic nucleotides in platelet function.
    Haslam RJ
    Ciba Found Symp; 1975; 35():121-51. PubMed ID: 179765
    [No Abstract]   [Full Text] [Related]  

  • 8. Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo.
    Willis AL; Comai K; Kuhn DC; Paulsrud J
    Prostaglandins; 1974 Dec; 8(6):509-19. PubMed ID: 4462154
    [No Abstract]   [Full Text] [Related]  

  • 9. Collagen-induced platelet aggregation: evidence of several mechanisms for the induction of platelet release by collagen.
    Nyman D
    Thromb Res; 1977 May; 10(5):743-51. PubMed ID: 882960
    [No Abstract]   [Full Text] [Related]  

  • 10. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
    Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
    Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
    MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
    Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
    [No Abstract]   [Full Text] [Related]  

  • 13. Butyltin compounds in vitro inhibition of human platelet epinephrine-induced aggregation and blockade of epinephrine binding to platelets.
    Yanagisawa H; Wada O
    Ind Health; 1985; 23(4):255-68. PubMed ID: 3938784
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet antiaggregating activity of imolamine: in vitro studies.
    Tremoli E; Maderna P; Cocuzza E; Mantero O
    Pharmacol Res Commun; 1979 Jan; 11(1):31-8. PubMed ID: 424437
    [No Abstract]   [Full Text] [Related]  

  • 15. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of raubasine and pipratecol on platelet aggregation and on the platelet release reaction].
    Cattaneo M; D'Angelo A; Mannucci PM; Pareti F; Vanasia S; Viganò
    Clin Ter; 1980 Feb; 92(4):359-68. PubMed ID: 6108818
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation].
    Antonikov IM; Alekseev OV; Chernukh AM
    Biull Eksp Biol Med; 1982 Apr; 93(4):11-3. PubMed ID: 6952942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion.
    White JG; Rao GH; Gerrard JM
    Am J Pathol; 1977 Aug; 88(2):387-402. PubMed ID: 879276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ticlopidine administration to humans on the binding of adenosine diphosphate to blood platelets.
    Lips NP; Sixma JJ; Schiphorst ME
    Thromb Res; 1980 Jan 1-15; 17(1-2):19-27. PubMed ID: 7376129
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of halofenate and clofibrate on aggregation and release of serotonin by human platelets.
    Lin CY; Smith S
    Life Sci; 1976 Mar; 18(6):563-8. PubMed ID: 1263738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.